Skip to content

Staar Surgical STAA Price / earnings

Price / earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
LENSAR, Inc. logo
LENSAR, Inc.LNSR
2.4×
IAR
Integra LifeSciencesIART
95.8×+70.8×
Align Technology logo
Align TechnologyALGN
28.4×-0.1×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
52×+12.2×
ITG
Integer HoldingsITGR
21.4×-32.6×

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.43B+66.0%
Enterprise value$1.33B+84.9%
P/S4.9×+1.8×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

Based on the most recent quarter.

The official record: Staar Surgical’s 10-Q, filed October 30, 2024, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's price / earnings?
Staar Surgical (STAA) reported price / earnings of 65.5× in Q3 2024.
How has Staar Surgical's price / earnings changed year-over-year?
Staar Surgical's price / earnings decreased by 34.7% year-over-year, from 100.3× to 65.5×.
What is the long-term trend for Staar Surgical's price / earnings?
Over 3 years (2020 to 2023), Staar Surgical's price / earnings has grown at a -57.3% compound annual growth rate (CAGR), from 825.8× to 64.2×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.